IHH Healthcare has announced a major growth strategy to increase its hospital bed capacity in India to about 7,000 beds by 2028, marking a significant expansion of its footprint in the country’s healthcare sector. This move follows the completion of its open offer to acquire a larger shareholding in Fortis Healthcare.
After the open offer concluded, IHH’s ownership in Fortis Healthcare stands at 31.17%, while its stake in Malar Hospitals has risen to 62.73%.
According to IHH Healthcare Group CEO Prem Kumar Nair, “The completion of the Fortis open offer allows us to move decisively into the next phase of growth in India. This comes at a pivotal time as IHH undertakes a group-wide transformation to future-proof our business.” He noted that the company is well placed to boost innovation, enhance patient care, and consistently deliver value in India’s rapidly changing healthcare environment.
Nair also highlighted the importance of collaboration between Fortis Healthcare and Gleneagles Healthcare India, saying, “Through strategic collaborations, including deeper synergies between Fortis Healthcare and Gleneagles Healthcare India, we aim to unlock operational efficiencies and elevate care delivery for patients across the country.”
Ashok Pandit, Group Chief Corporate Officer at IHH Healthcare, added that the company is on track to grow its capacity by over one-third by 2028. Currently, IHH’s network includes 35 hospitals with more than 5,000 beds across 11 Indian states, and the plan is to add about 2,000 new beds in the next few years to achieve the 7,000-bed target.
This expansion strategy reflects IHH Healthcare’s confidence in India’s healthcare demand and demonstrates a strengthening of its presence in one of the world’s fastest-growing private healthcare markets.